Global Implantable Remote Patient Monitoring Devices Market
商品番号 : SMB-76749
出版社 | BCC Research |
出版年月 | 2025年4月 |
ページ数 | 140 |
価格タイプ | シングルユーザライセンス |
価格 | USD 4,650 |
種別 | 英文調査報告書 |
Report Highlights
The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.
埋め込み型遠隔患者モニタリング(IRPM)デバイスの世界市場は、2023年に65億ドルと評価されました。この市場は、2024年の76億ドルから2029年末には203億ドルに成長し、2024年から2029年にかけて年平均成長率(CAGR)は21.7%になると予想されています。
Report Scope
The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
本レポートは、市場の埋め込み型遠隔患者モニタリング(IRPM)デバイスに関する詳細情報を提供しています。2029年までの市場予測と主要企業の市場ランキングを提供しています。レポートでは、製品、適応症、エンドユーザーに基づいて、IRPMデバイスの市場シェアを詳述しています。この市場は、製品に基づいて、埋め込み型心血管モニタリングデバイス、埋め込み型脳モニタリングデバイス、胃腸モニタリング(スマートピル)、埋め込み型血液モニタリングデバイス、埋め込み型呼吸モニタリングデバイス、埋め込み型筋骨格モニタリングデバイス、その他に分類されています。適応症に基づいて、市場は心血管疾患、脳疾患、胃腸疾患、糖尿病、慢性呼吸器疾患、筋骨格疾患、その他に分類されています。エンドユーザー別には、市場は病院や診療所、在宅医療環境、その他に分類されています。詳細な競争環境には、主要プレーヤー、市場シェア、および最近の戦略的開発が含まれます。
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Synopsis
Report Metrics | Details | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2023 | ||||||||||||||||
Forecast period considered | 2024-2029 | ||||||||||||||||
Base year market size | $6.5 Billion | ||||||||||||||||
Market size forecast | $20.3 Billion | ||||||||||||||||
Growth rate | CAGR of 21.7% from 2024 to 2029 | ||||||||||||||||
Units considered | $ Millions | ||||||||||||||||
Segments covered | By Product, Disease Indication, End User, and Region | ||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and the Rest of World (RoW) | ||||||||||||||||
Key Market Drivers |
| ||||||||||||||||
Companies studied |
|
Report Includes
– 32 data tables and 47 additional tables
– An overview of the global market for implantable remote patient monitoring (IRPM) devices
– Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
– Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
– Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
– Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
– Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
– A discussion of the industry’s ESG challenges and practices
– Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
– Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
– Identification of the major stakeholders and analysis of recent developments and segmental revenues
– Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry
Supply Chain Analysis
R&D, Product Design and Early Prototyping
Regulatory Submissions and Approvals
Raw Material Procurement
Manufacturing IRPM Devices
Distribution and Sales
Post-Sales Services
Chapter 3 Market Dynamics
Market Dynamics Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and an Aging Population
Growing Demand for mHealth Applications
Improved Wireless Communication Technologies
Market Restraints
Data Privacy Concerns
Stringent Government Regulations
Market Opportunities
Emerging Markets
Market Challenges
Integration with Healthcare Systems
Chapter 4 Regulatory Landscape
Regulatory Framework
United States
European Union
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies in the IRPM Devices Market
Artificial Intelligence and Machine Learning
Nanotechnology-based Devices
Biocompatible Materials
Patent Analysis
Patents by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Top Inventor
Patents by Jurisdiction
Chapter 6 Market Segment Analysis
Segmentation Breakdown
IRPM Devices: Global Markets
Market Analysis by Product
Implantable Cardiovascular Monitoring Devices
Implantable Brain Monitoring Devices
Gastrointestinal Monitoring (Smart Pills)
Implantable Hematological Monitoring Devices
Implantable Respiratory Monitoring Devices
Implantable Musculoskeletal Monitoring Devices
Others
Market Analysis by Indication
Cardiovascular Diseases
Brain Disorders
Gastrointestinal Diseases
Diabetes
Chronic Respiratory Diseases
Musculoskeletal Diseases
Others
Market Analysis by End User
Hospital and Clinics
Home Healthcare Settings
Other End-users
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective in IRPM Devices
Sustainability in the IRPM Devices Industry
Understanding the ESG Data
Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
Overview
Key Strategies for IRPM Devices Manufacturers
Distribution Networks
Product Mapping
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT
List of Tables
Summary Table : Global Market for Implantable Remote Patient Monitoring Devices, by Region, Through 2029
Table 1 : Worldwide Diabetes Population, by WHO Region, 2021-2045
Table 2 : Global Elderly Population, by Country, 2022 and 2023
Table 3 : Notified Regulatory Bodies, By Country
Table 4 : Patents Granted for IRPM Devices, by Top Applicant, 2021-2024
Table 5 : Patents Granted for Implantable Remote Patient Monitoring Devices, by Top Owner, 2021–2024
Table 6 : Patents Granted for IRPM Devices, by Top Inventor, 2021-2024
Table 7 : Patents Granted for IRPM Devices, by Jurisdiction, 2021-2024
Table 8 : Global Market for IRPM Devices, Through 2029
Table 9 : Global Market for IRPM Devices, by Product, Through 2029
Table 10 : Smart Pills
Table 11 : Global Market for IRPM Devices, by Indication, Through 2029
Table 12 : Global Market for IRPM Devices, by End User, Through 2029
Table 13 : Global Market for IRPM Devices, by Region, Through 2029
Table 14 : North American Market for IRPM Devices, by Country, Through 2029
Table 15 : North American Market for Implantable Remote Patient Monitoring Devices, by Product, Through 2029
Table 16 : North American Market for IRPM Devices, by Indication, Through 2029
Table 17 : North American Market for IRPM Devices, by End User, Through 2029
Table 18 : European Market for IRPM Devices, by Country, Through 2029
Table 19 : European Market for IRPM Devices, by Product, Through 2029
Table 20 : European Market for IRPM Devices, by Indication, Through 2029
Table 21 : European Market for IRPM Devices, by End User, Through 2029
Table 22 : Asia-Pacific Market for IRPM Devices, by Country, Through 2029
Table 23 : Asia-Pacific Market for IRPM Devices, by Product, Through 2029
Table 24 : Asia-Pacific Market for IRPM Devices, by Indication, Through 2029
Table 25 : Asia-Pacific Market for IRPM Devices, by End User, Through 2029
Table 26 : RoW Market for IRPM Devices, by Product, Through 2029
Table 27 : RoW Market for IRPM Devices, by Indication, Through 2029
Table 28 : RoW Market for IRPM Devices, by End User, Through 2029
Table 29 : ESG Rankings for Major IRPM Devices Companies, 2024*
Table 30 : IRPM Devices: Major Players
Table 31 : Implantable Cardiovascular Monitoring Device Product Mapping
Table 32 : Glossary of Terms Used in Global Market for Implantable Remote Patient Monitoring Devices
Table 33 : Information Sources for this Report
Table 34 : Abbott: Company Snapshot
Table 35 : Abbott: Financial Performance, FY 2022 and 2023
Table 36 : Abbott: Product Portfolio
Table 37 : Abbott: News/Key Developments, 2023 and 2024
Table 38 : Avertix Medical Inc.: Company Snapshot
Table 39 : Avertix Medical Inc.: Product Portfolio
Table 40 : Avertix Medical Inc.: News/Key Developments, 2023
Table 41 : Biotronik: Company Snapshot
Table 42 : Biotronik: Product Portfolio
Table 43 : Biotronik: News/Key Developments, 2023
Table 44 : Boston Scientific Corp.: Company Snapshot
Table 45 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 46 : Boston Scientific Corp.: Product Portfolio
Table 47 : Boston Scientific Corp.: News/Key Developments, 2024
Table 48 : Cardiac RMS: Company Snapshot
Table 49 : Cardiac RMS: Product Portfolio
Table 50 : Dexcom Inc.: Company Snapshot
Table 51 : Dexcom Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Dexcom Inc.: Product Portfolio
Table 53 : Dexcom Inc.: News/Key Developments, 2024
Table 54 : EBR Systems Inc.: Company Snapshot
Table 55 : EBR Systems Inc.: Financial Performance, FY 2022 and 2023
Table 56 : EBR Systems Inc.: Product Portfolio
Table 57 : EBR Systems Inc.: News/Key Developments, 2024
Table 58 : Endotronix Inc.: Company Snapshot
Table 59 : Endotronix Inc.: Product Portfolio
Table 60 : Endotronix Inc.: News/Key Developments, 2024
Table 61 : InjectSense Inc.: Company Snapshot
Table 62 : InjectSense Inc.: Product Portfolio
Table 63 : InjectSense Inc.: News/Key Developments, 2024
Table 64 : Impulse Dynamics: Company Snapshot
Table 65 : Impulse Dynamics: Product Portfolio
Table 66 : Impulse Dynamics: News/Key Developments, 2024
Table 67 : Medico S.R.L.: Company Snapshot
Table 68 : Medico S.R.L.: Product Portfolio
Table 69 : Medtronic: Company Snapshot
Table 70 : Medtronic: Financial Performance, FY 2022 and 2023
Table 71 : Medtronic: Product Portfolio
Table 72 : Medtronic: News/Key Developments, 2023 and 2024
Table 73 : Profusa Inc.: Company Snapshot
Table 74 : Profusa Inc.: Product Portfolio
Table 75 : Qura LLC.: Company Snapshot
Table 76 : Qura LLC.: Product Portfolio
Table 77 : VitalConnect: Company Snapshot
Table 78 : VitalConnect: Product Portfolio
List of Figures
Summary Figure : Global Market for Implantable Remote Patient Monitoring Devices, by Region, 2021–2029
Figure 1 : Supply Chain Analysis of Implantable Remote Patient Monitoring Devices Industry
Figure 2 : Market Dynamics of IRPM Devices Market
Figure 3 : Emerging Trends and Technologies in IRPM Devices
Figure 4 : Patents Granted for IRPM Devices, by Year, 2021–2024
Figure 5 : Share of Global Market for IRPM Devices, by Product, 2023
Figure 6 : Share of Global Market for IRPM Devices, by Indication, 2023
Figure 7 : Share of Global Market for IRPM Devices, by End User, 2023
Figure 8 : Share of Global Market for IRPM Devices, by Region, 2023
Figure 9 : Share of North American Market for IRPM Devices, by Country, 2023
Figure 10 : North American Market for IRPM Devices, 2021–2029
Figure 11 : Share of North American Market for IRPM Devices, by Product, 2023
Figure 12 : Share of North American Market for IRPM Devices, by Indication, 2023
Figure 13 : Share of North American Market for IRPM Devices, by End User, 2023
Figure 14 : Share of European Market for IRPM Devices, by Country, 2023
Figure 15 : European Market for IRPM Devices, 2021–2029
Figure 16 : Share of European Market for IRPM Devices, by Product, 2023
Figure 17 : Share of European Market for IRPM Devices, by Indication, 2023
Figure 18 : Share of European Market for IRPM Devices, by End User, 2023
Figure 19 : Share of Asia-Pacific Market for IRPM Devices, by Country, 2023
Figure 20 : Asia-Pacific Market for IRPM Devices, 2021–2029
Figure 21 : Share of Asia-Pacific Market for IRPM Devices, by Product, 2023
Figure 22 : Share of Asia-Pacific Market for IRPM Devices, by Indication, 2023
Figure 23 : Share of Asia-Pacific Market for IRPM Devices, by End User, 2023
Figure 24 : RoW Market for IRPM Devices, 2021–2029
Figure 25 : Share of RoW Market for IRPM Devices, by Product, 2023
Figure 26 : Share of RoW Market for IRPM Devices, by Indication, 2023
Figure 27 : Share of RoW Market for IRPM Devices, by End User, 2023
Figure 28 : Key ESG Metrics for Companies in the IRPM Devices Industry
Figure 29 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 30 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 31 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 32 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 33 : Dexcom Inc.: Revenue Share, by Sales Channel, FY 2023
Figure 34 : Dexcom Inc.: Revenue Share, by Country/Region, FY 2023
Figure 35 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 36 : Medtronic: Revenue Share, by Country/Region, FY 2023
BCC Research(BCCリサーチ)はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 不織布ろ材の世界市場 2025-05-07
- 世界のグリーンスチール市場 2025-05-05
- デジタルパソロジーの技術と世界市場 2025-04-29
- 持続可能エネルギーの調査レビュー 2024年 2025-04-22
- 世界の燃料電池スタック市場 2025-04-22